Cargando…

Beyond the Driver Mutation: Immunotherapies in Gastrointestinal Stromal Tumors

Gastrointestinal stromal tumors (GISTs) are a subtype of soft tissue sarcoma (STS), and have become a concept of oncogenic addiction and targeted therapies.The large majority of these tumors develop after a mutation in KIT or platelet derived growth factor receptor α (PDGFRα), resulting in uncontrol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roulleaux Dugage, Matthieu, Jones, Robin Lewis, Trent, Jonathan, Champiat, Stéphane, Dumont, Sarah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8417712/ https://www.ncbi.nlm.nih.gov/pubmed/34489967 http://dx.doi.org/10.3389/fimmu.2021.715727

Ejemplares similares

Improving Immunotherapy Efficacy in Soft-Tissue Sarcomas: A Biomarker Driven and Histotype Tailored Review
por: Roulleaux Dugage, Matthieu, et al.
Publicado: (2021)

New immunotherapy strategies for patients with sarcomas: highlights from the 2023 ASCO annual meeting
por: Roulleaux-Dugage, Matthieu, et al.
Publicado: (2023)

Immunotherapy Strategies for Gastrointestinal Stromal Tumor
por: Arshad, Junaid, et al.
Publicado: (2021)

Twitter as a Medical Media Among French Young Oncologists: Results from a National Survey
por: Roulleaux Dugage, Matthieu, et al.
Publicado: (2021)

Case Report: Response to Immunotherapy, Can Radiotherapy Be a Troublemaker?
por: Martin-Romano, Patricia, et al.
Publicado: (2021)

Metastatic Renal Medullary and Collecting Duct Carcinoma in the Era of Antiangiogenic and Immune Checkpoint Inhibitors: A Multicentric Retrospective Study
por: Guillaume, Zoé, et al.
Publicado: (2022)

Gastrointestinal stromal tumor and its targeted therapeutics
por: Dupart, Jheri, et al.
Publicado: (2011)

CD73's Potential as an Immunotherapy Target in Gastrointestinal Cancers
por: Harvey, Jerry B., et al.
Publicado: (2020)

Gastrointestinal stromal tumor: Role of surgery and immunotherapy
por: Bhatnagar, Sushmita N.
Publicado: (2010)

De novo priming: driver of immunotherapy responses or epiphenomenon?
por: Young, Alexander L., et al.
Publicado: (2023)

Further Advances in Cancer Immunotherapy: Going Beyond Checkpoint Blockade
por: Wilkinson, Robert W., et al.
Publicado: (2018)

Immunotherapy of COVID-19: Inside and Beyond IL-6 Signalling
por: Zizzo, Gaetano, et al.
Publicado: (2022)

Immune Infiltration, Cancer Stemness, and Targeted Therapy in Gastrointestinal Stromal Tumor
por: Wang, Jingjing, et al.
Publicado: (2021)

Targeted Immunotherapies in Gastrointestinal Cancer: From Molecular Mechanisms to Implications
por: Wang, Ding-Kang, et al.
Publicado: (2021)

Combinational Immunotherapy for Hepatocellular Carcinoma: Radiotherapy, Immune Checkpoint Blockade and Beyond
por: Lee, Yun Hua, et al.
Publicado: (2020)

Cell atlas of the immune microenvironment in gastrointestinal cancers: Dendritic cells and beyond
por: Wang, Yinuo, et al.
Publicado: (2022)

The diagnosis, classification, and treatment of sarcoma in this era of artificial intelligence and immunotherapy
por: Crombé, Amandine, et al.
Publicado: (2022)

Advances in Human Dendritic Cell-Based Immunotherapy Against Gastrointestinal Cancer
por: Ni, Ling
Publicado: (2022)

Tumor Microenvironment Evaluation for Gastrointestinal Cancer in the Era of Immunotherapy and Machine Learning
por: Ye, Zilan, et al.
Publicado: (2022)

Editorial: Tumor microenvironment, immunotherapy, and drug resistance in breast and gastrointestinal cancer
por: Deng, Xinpei, et al.
Publicado: (2023)

Intratumoural administration and tumour tissue targeting of cancer immunotherapies
por: Melero, Ignacio, et al.
Publicado: (2021)

Mutation-Derived Neoantigens for Cancer Immunotherapy
por: Castle, John C., et al.
Publicado: (2019)

Targeting myeloid-derived suppressor cells in tumor immunotherapy: Current, future and beyond
por: Zhao, Yang, et al.
Publicado: (2023)

Host-Related Factors as Targetable Drivers of Immunotherapy Response in Non-Small Cell Lung Cancer Patients
por: Baci, Denisa, et al.
Publicado: (2022)

Editorial: Gastrointestinal cancer immunotherapy: from drug resistance mechanisms to overcoming strategies
por: Shi, Tao, et al.
Publicado: (2023)

Human virome profiling identified CMV as the major viral driver of a high accumulation of senescent CD8(+) T cells in patients with advanced NSCLC
por: Naigeon, Marie, et al.
Publicado: (2023)

Promising Immunotherapy in Metastatic Testicular Sex Cord Stromal Tumours After First-Line Chemotherapy
por: Shang, Bingqing, et al.
Publicado: (2022)

An unusual site of metastasis from gastrointestinal stromal tumor
por: Cauchi, Carolina, et al.
Publicado: (2010)

Long-Term Clinical and Immunological Profile of Kidney Transplant Patients Given Mesenchymal Stromal Cell Immunotherapy
por: Perico, Norberto, et al.
Publicado: (2018)

The favorable impact of PIK3CA mutations on survival: an analysis of 2587 patients with breast cancer
por: Dumont, Amaury G., et al.
Publicado: (2012)

Recent advances in the systemic treatment of gastrointestinal stromal tumors
por: Jones, Robin L., et al.
Publicado: (2023)

Optimal Avapritinib Treatment Strategies for Patients with Metastatic or Unresectable Gastrointestinal Stromal Tumors
por: Joseph, Cissimol P., et al.
Publicado: (2021)

Commentary: Beyond C4: Analysis of the complement gene pathway shows enrichment for IQ in patients with psychotic disorders and healthy controls
por: Coulthard, Liam G., et al.
Publicado: (2019)

Baseline Gastrointestinal Eosinophilia Is Common in Oral Immunotherapy Subjects With IgE-Mediated Peanut Allergy
por: Wright, Benjamin L., et al.
Publicado: (2018)

Frequent KIT Mutations in Human Gastrointestinal Stromal Tumors
por: Xu, Zhi, et al.
Publicado: (2014)

Diabetic complications and prospective immunotherapy
por: Reynolds, Lewis, et al.
Publicado: (2023)

CD1d-Invariant Natural Killer T Cell-Based Cancer Immunotherapy: α-Galactosylceramide and Beyond
por: King, Lisa A., et al.
Publicado: (2018)

Aspartate and Acetate Fuel Gastrointestinal Stromal Tumors Beyond the Warburg Effect
por: Lai, Ying-Chieh, et al.
Publicado: (2022)

Neoantigens Generated by Individual Mutations and Their Role in Cancer Immunity and Immunotherapy
por: Efremova, Mirjana, et al.
Publicado: (2017)

Advances in Immune Microenvironment and Immunotherapy of Isocitrate Dehydrogenase Mutated Glioma
por: Yan, Dongming, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cs88mtf5ramqhn64qv9jucbdcf